| FARN Stock | | | 170.00 2.50 1.49% |
Faron Pharmaceuticals financial indicator trend analysis is much more than just examining Faron Pharmaceuticals latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Faron Pharmaceuticals is a good investment. Please check the relationship between Faron Pharmaceuticals Accounts Payable and its Total Current Assets accounts. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Faron Pharmaceuticals Oy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Accounts Payable vs Total Current Assets
Accounts Payable vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Faron Pharmaceuticals Accounts Payable account and
Total Current Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Faron Pharmaceuticals' Accounts Payable and Total Current Assets is 0.4. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Faron Pharmaceuticals Oy, assuming nothing else is changed. The correlation between historical values of Faron Pharmaceuticals' Accounts Payable and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Faron Pharmaceuticals Oy are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Accounts Payable i.e., Faron Pharmaceuticals' Accounts Payable and Total Current Assets go up and down completely randomly.
Correlation Coefficient | 0.4 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Accounts Payable
An accounting item on the balance sheet that represents Faron Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Faron Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.
Most indicators from Faron Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Faron Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Faron Pharmaceuticals Oy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Selling General Administrative is likely to gain to about 9.1
M in 2024, whereas
Tax Provision is likely to drop 0.00 in 2024.
Faron Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Faron Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Faron Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Faron Stock Analysis
When running Faron Pharmaceuticals' price analysis, check to
measure Faron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faron Pharmaceuticals is operating at the current time. Most of Faron Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Faron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Faron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.